DM919 / D2M biotherap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
DM919 / D2M biotherap
NCT06328673: A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors

Recruiting
1
160
US
DM919, Pembrolizumab, Keytruda
D2M Biotherapeutics Inc.
Advanced Solid Tumor
12/25
03/26

Download Options